NEVVI Medicare utilization intelligence
or

← back

Provider profile

TREVINO, ABRAM MD

Medical Oncology · NPI 1346323888 · NEW BRAUNFELS, TX

1
Groups
57
Codes · 2024
38,459
Disclosed services

TREVINO, ABRAM is a Medical Oncology in NEW BRAUNFELS, TX, a member of 1 medical group, who billed 57 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

38,459
disclosed services
57
codes billed to Medicare Part B
Prior year · CY2023 35,904 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1453 Injection, fosaprepitant, 1 mg
80053 Blood test, comprehensive group of blood chemicals
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2469 Injection, palonosetron hcl, 25 mcg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
J1626 Injection, granisetron hydrochloride, 100 mcg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
83615 Lactate dehydrogenase (enzyme) level
83521 Measurement of immunoglobulin light chains
82784 Gammaglobulin (immune system protein) measurement
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96413 Administration of chemotherapy into vein, 1 hour or less
84153 Psa (prostate specific antigen) measurement, total
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
71260 Ct scan of chest with contrast
84403 Testosterone (hormone) level, total
J3489 Injection, zoledronic acid, 1 mg
74177 Ct scan of abdomen and pelvis with contrast
85046 Red blood count automated, with additional calculations
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96372 Injection of drug or substance under skin or into muscle
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85610 Blood test, clotting time
96375 Injection of additional new drug or substance into vein
82746 Folic acid level, serum
82607 Cyanocobalamin (vitamin b-12) level
82378 Carcinoembryonic antigen (cea) protein level
85055 Reticulated (young) platelet measurement
96417 Administration of additional new drug or substance into vein, 1 hour or less
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
84443 Blood test, thyroid stimulating hormone (tsh)
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96523 Irrigation of implanted venous access drug delivery device
85652 Red blood cell sedimentation rate, to detect inflammation, automated
85730 Coagulation assessment blood test, plasma or whole blood
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
71250 Ct scan of chest without contrast
83010 Haptoglobin (serum protein) level
86140 Measurement c-reactive protein for detection of infection or inflammation
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
70491 Ct scan of soft tissue of neck with contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.